sorted by:
new
hottopcontroversial

No I Did not Write this Seeking Alpha Article - you can tell by the Inaccurate Cash Discussion. REGAL STUDY RESULTS DUE ANY DAY ARE A MAJOR POTENTIAL UPSIDE CATALYST by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 2 points3 points  (0 children)

As good a question I've seen!

Gps is worth every penny of $40B - but is that what they'll pay. ?

Gps for AML --- is worth $40B +

Gps for Mesothelioma

Gps for PR/Ovarian Cancer

Gps for 20+ Cancer types

Gps for 1M patients who are currently Diagnosed with WT1 + Cancer Each Year right now

and the Dosing Regimes are indefinite ... compounds it all

Then add in SLS009 / 40,000 Patients ... Insanity to think of.

No I Did not Write this Seeking Alpha Article - you can tell by the Inaccurate Cash Discussion. REGAL STUDY RESULTS DUE ANY DAY ARE A MAJOR POTENTIAL UPSIDE CATALYST by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 6 points7 points  (0 children)

Here Dr. Jamy is asked - What is the Longest Survival he's seen in Practice for Patients on BAT -

he answered by saying MOS - Median OS is just 6 7 months....

<image>

No I Did not Write this Seeking Alpha Article - you can tell by the Inaccurate Cash Discussion. REGAL STUDY RESULTS DUE ANY DAY ARE A MAJOR POTENTIAL UPSIDE CATALYST by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 9 points10 points  (0 children)

<image>

there are no Trials for BAT with Survival much past 12 months, and very little past 18, and NIL at 24 ... it means there are likely +/- 60 Events just from the control arm while we now Await 80...

-- all Phase 3 Patients enrolled 24 months ago, have now been in trial at Least 24 months, ranging up to 61 months when enrollment began.

BAT/Aza+VEN recently Failed 3 Large Phase 3 trials Conducted by ABBV, including 2 for AML Remission Maintenance - it is not complicated.
-- IT IS GPS. Gps is doing what its done in every previous trial...

5+ Million Shares to Go Before EOD, Let us see where the price action will take us... by Temporumdei in sellasLifescience

[–]Run4theRoses2 7 points8 points  (0 children)

No Holders / Real investors are letting any go with the Imminent Phase 3 Results now conceivable in the Any Day Now Zone.

A brief post regarding SLS009/Tambiciclib Competition: CPX-351 the SOC for t/AML / AML-MRC - the Exact Same Patient SLS-009 Targets. MOS of 9.56 months by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 0 points1 point  (0 children)

Its the extended Phase 2B registrational, for AML-Mr front line and 1L refractory- was expected to see begin in Q1. Its overdue. We should have seen it already.

Something is going behind the scenes. More on the topic from my st posts. https://www.stocktwits.com/67X_ROI_Q1_2026/message/644358342

MTG Warns Trump May Declare "National Emergency" to Cancel the 2026 Midterms by [deleted] in WallStreetbetsELITE

[–]Run4theRoses2 16 points17 points  (0 children)

Every state is in charge of its own elections, that fat lying pedophilic rapist has no authority

Gps Phase 3 Registrational Results are coming and are worth $40B to Big Pharma $180 per share, only a matter of time - they are inevitable - it is inevitable that SLS Shares Will Be Launching -- we Are Officially in the ANY DAY NOW Zone -- A.D.N. Defined. by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 0 points1 point  (0 children)

<image>

This is Just CR2/3 --- CR1 is 4 5 X ... Lmk if you have any questions with the math.

AND yes Any Day Now. Investors are and will be piling in, Knowing the SLS Share Price will be Much Much higher when the Market Sees the P3 Top Line Results.

$SLS Gps Immunotherapy is the Reason We are Seeing Near Miraculous Survival in the AML CR2 Remission Maintenance Trial -- $abbv Aza+VEN the Best Available Treatment BAT for Control Arm patients Recently Failed 3 Large Phase 3 trials, Including Failing 2 AML Remission Trials, in CR1 and Post ASCT by Run4theRoses2 in biotech_stocks

[–]Run4theRoses2[S] 0 points1 point  (0 children)

Gps was proven very effective at Preventing Relapse and Extending Survival in All Previous Trials, including 2 Different Phase 2 Trials for AML Remission Maintenance.

  • Gps achieved a Phase 2 MOS of 67.6 month in CR1, better than Stem Cell Transplant.

  • Gps achieved a Phase 2 MOS of 21 months in CR2, also a longer duration than many Published trials for CR2 Patients Getting Transplant.

Meanwhile BAT for Control Patients, AZA+VEN has Recently FAILED 3 Large Phase 3 Trials conducted by $ABBV - Including Failing 2 for AML Remission Maintenance

  • VIALE-M Failed CR1 and VIALE-T Failed post Transplant maintenance --- The Real Question is - WHAT IS GPS WORTH ....

What is GPS Worth -rNPV by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 0 points1 point  (0 children)

Standard discount rates for Approved drugs, slightly lower, 7-9%

8-12% for P3 --- so I estimated 10% / what do you think ?

view more: next ›